As the U.S. prepares to welcome a new presidential administration, leaders from business, public health, and community organizations gathered in Atlanta last week to reaffirm their dedication to ending the HIV epidemic and improving access to prevention and care.
“Because of years of research and scientific advancements, we now have the tools to prevent and treat HIV and keep people living healthy and long lives,” said Carl Schmid, executive director of HIV+Hepatitis Policy Institute. “Now is not the time to retreat on our commitment to protecting the health of our nation. President Trump initiated the Ending the HIV Epidemic initiative in his first term, which was sustained by President Biden and his administration. Now we look forward to that same commitment from President Trump as he and his new administration seek to make our country healthier, bolster prevention, and address chronic diseases.”
The American people have spoken and elected Donald Trump and JD Vance as our next President and Vice President. The HIV+Hepatitis Policy Institute will work with the new administration on furthering efforts to end HIV and hepatitis in the United States. With proper leadership, policies, and funding, we can end both these infectious diseases.
“While we appreciate the sustained funding for many domestic HIV and hepatitis programs, we are devastated by the proposal to virtually eliminate the Ending the HIV Epidemic initiative,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We were on a trajectory to end HIV by ensuring all people have access to care and treatment, and prevent new infections through increasing access to PrEP, but now all those efforts will be lost. This bill cannot stand as is.”
Washington DC… In the final hours of the Trump administration, Seema Verma, former administrator of the Centers for Medicare and Medicaid Services (CMS), announced a Medicare Part D demonstration project…